Description
CJC-1295 is a synthetic growth hormone–releasing factor analog utilized in laboratory and preclinical research to evaluate growth hormone signaling, receptor binding, and peptide half-life. It is commonly studied in controlled research models to better understand GH pulse amplification, endocrine pathway interactions, and peptide stability under various conditions.
